Author:
Pan Xiaoli,Hu Shuwei,Xu Yanyong,Gopoju Raja,Zhu Yingdong,Cassim Bawa Fathima N.,Wang Hui,Wang Jiayou,Batayneh Zaid,Clark Alyssa,Zeng Yuhao,Lin Li,Wang Xinwen,Yin Liya,Zhang Yanqiao
Funder
National Institutes of Health
Reference30 articles.
1. Endocrine aspects of metabolic dysfunction associated steatotic liver disease (MASLD): beyond insulin resistance;Hutchison;J Hepatol,2023
2. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis;Riazi;Lancet Gastroenterol Hepatol,2022
3. Functional role of KLF10 in multiple disease processes;Subramaniam;Biofactors,2010
4. KLF10 as a tumor suppressor gene and its TGF-beta signaling;Memon;Cancers (Basel),2018
5. KLF10 integrates circadian timing and sugar signaling to coordinate hepatic metabolism;Ruberto;Elife,2021